Özcan, M., Cassaday, R. D., Zarzycka, E., Vandendries, E., Zhang, F., Chen, Y., Nieto, A., Demirkan, F., Montesinos, P. and Altuntas, F. (2020) “Efficacy and safety of currently approved and lower starting doses of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukemia: a phase IV study”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2024.286091.